157 related articles for article (PubMed ID: 20332023)
1. Alzheimer's disease: old problem, new views from transgenic and viral models.
Jaworski T; Dewachter I; Seymour CM; Borghgraef P; Devijver H; Kügler S; Van Leuven F
Biochim Biophys Acta; 2010 Oct; 1802(10):808-18. PubMed ID: 20332023
[TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
3. Transgenic animal models of tauopathies.
Lee VM; Kenyon TK; Trojanowski JQ
Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
[TBL] [Abstract][Full Text] [Related]
4. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
6. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
8. Mouse models of neurodegenerative diseases: criteria and general methodology.
Janus C; Welzl H
Methods Mol Biol; 2010; 602():323-45. PubMed ID: 20012407
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy Models of Alzheimer's Disease and Other Dementias.
Combs B; Kneynsberg A; Kanaan NM
Methods Mol Biol; 2016; 1382():339-66. PubMed ID: 26611599
[TBL] [Abstract][Full Text] [Related]
10. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.
Ballatore C; Lee VM; Trojanowski JQ
Nat Rev Neurosci; 2007 Sep; 8(9):663-72. PubMed ID: 17684513
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F
Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tau pathology in tau transgenic models.
Brion JP; Ando K; Heraud C; Leroy K
Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
[TBL] [Abstract][Full Text] [Related]
16. Searching for new animal models of Alzheimer's disease.
Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
[TBL] [Abstract][Full Text] [Related]
17. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
18. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
19. Genetic mouse models of Alzheimer's disease.
Mineur YS; McLoughlin D; Crusio WE; Sluyter F
Neural Plast; 2005; 12(4):299-310. PubMed ID: 16444901
[TBL] [Abstract][Full Text] [Related]
20. Tauopathy models and human neuropathology: similarities and differences.
Frank S; Clavaguera F; Tolnay M
Acta Neuropathol; 2008 Jan; 115(1):39-53. PubMed ID: 17786456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
